Yaning Yang

5PUBLICATIONS
10CO-AUTHORS
Cell development, proliferation and deathPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 12, 2026
Cell stress and death liberate the autophagy-inhibitory tissue stress hormone DBI/ACBP into the circulation.

|May 06, 2026
Potential of Minimal Residual Disease in Guiding Adjuvant Therapy Decisions in Non-Small Cell Lung Cancer.

|Nov 01, 2023
Immunotherapy as a later-line option for HER2-altered advanced non-small-cell lung cancer: taxane might be a favorable partner.

Yaning Yang, Guangjian Yang, Weihua Li

|Oct 06, 2021
Possibility of brigatinib-based therapy, or chemotherapy plus anti-angiogenic treatment after resistance of osimertinib harboring EGFR T790M-cis-C797S mutations in lung adenocarcinoma patients.

Yaning Yang, Haiyan Xu, Li Ma

|Nov 14, 2019
The value of blood biomarkers of progression and prognosis in ALK-positive patients with non-small cell lung cancer treated with crizotinib.

Yaning Yang, Haiyan Xu, Guangjian Yang

Pageof 1

Frequent Collaborators

3 joint publications

Yan Wang

1 joint publications

Lu Yang

1 joint publications

Siyu Lei

1 joint publications

Yousheng Mao